ENG in Medical Technology

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

...ients. N Engl J Med 2000; 342:145-53. (3) The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N eng J Med 2008; 358(15):1547-59. (4) Israili ZH, Hall WD. Cough and angioedema associated with angiotensin-converting enzyme inhibitor therapy. A review...